Ashland Executive Compensation (FY25)
ASH · Wilmington, DE · Executive and director compensation, fiscal 2022 to 2025
Chief executive, fiscal 2025 ◇ Guillermo Novo | Median of the other named officers $1,915,000 6 officers, excluding the chief executive | Latest say-on-pay support = January 20, 2026 | Chief executive pay ratio ◇ To the median employee |
Velarion Intel, $5,000/year: one seat · one year · every company we cover, with dashboards, peer screens and board-ready briefs.
The Ashland brief, $500
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $500 for the board report; $900 for both.
Data as of November 5, 2026Latest filing (8-K): January 22, 2026
14 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Velarion Intel, one year, every company
308 figures on this page: 298 cited to the filing that reported them, 10 calculated from figures it prints. See the citations
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Guillermo Novo: $8,981,991 → $7,907,423 (12.0% lower)
Say-on-pay support: 97.6% → 96.7% (0.9 points lower)
CEO pay ratio: 117:1 → 83:1 (29.1% lower)
Frequently asked questions
Answers drawn from the data on this page.
Who is Ashland's chief executive and what were they paid?
Guillermo Novo was paid $7,907,423 in total compensation as Chair of the Board and Chief Executive Officer for fiscal 2025. Novo's total moved 12.0% lower from the $8,981,991 reported for fiscal 2024.
What was Ashland's say-on-pay result?
Shareholders supported the say-on-pay proposal with 96.7% of votes cast for or against in favor at the meeting held January 20, 2026 for fiscal 2025.
Which companies are in Ashland's peer group?
The disclosed peer group includes Albemarle Corporation, Avient Corporation, Axalta Coating Systems Ltd, Cabot Corporation and Element Solutions, Inc., among others.
What is Ashland's chief executive pay ratio?
For fiscal 2025, the company reported a chief executive pay ratio of 83:1, against median employee compensation of $95,293.
Executive compensation
Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Guillermo Novo Chair of the Board and Chief Executive Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
J. Kevin Willis Senior Vice President and Chief Financial Officer | ◇ | — | ◇ | — | ◇ | ◇ | ◇ | ◇† |
Osama Musa Senior Vice President and Chief Technology Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Min Chong Former SVP, GM Specialty Additives & Personal Care | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Ashok Kalyana SVP, GM Life Sciences | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Fiscal 2023
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Guillermo Novo Chair of the Board and Chief Executive Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
J. Kevin Willis Senior Vice President and Chief Financial Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Xiao Wang SVP, GM Personal Care | ◇ | — | ◇ | — | — | — | ◇ | ◇ |
Osama Musa Senior Vice President and Chief Technology Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Min Chong Former SVP, GM Specialty Additives & Personal Care | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Ashok Kalyana SVP, GM Life Sciences | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Fiscal 2024
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Guillermo Novo Chair and Chief Executive Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
J. Kevin Willis SVP, Chief Financial Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Min Chong Former SVP, GM Specialty Additives & Personal Care Departed during or after this year | ◇ | — | ◇ | — | — | — | ◇ | ◇ |
Alessandra Assis SVP & GM Life Sciences & Intermediates | ◇ | ◇ | ◇ | — | ◇ | — | ◇ | ◇ |
Osama Musa SVP, Chief Technology Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Karl Bostaph SVP Operations and Manufacturing | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Fiscal 2025
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Guillermo Novo Chair of the Board and Chief Executive Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
J. Kevin Willis Former Senior Vice President and Chief Financial Officer Departed during or after this year | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
William Whitaker Senior Vice President and Chief Financial Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Alessandra Faccin Assis Senior Vice President and General Manager, Life Sciences and Intermediates | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Osama Musa Senior Vice President and Chief Technology Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Karl Bostaph Former Senior Vice President Operations Departed during or after this year | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
James Minicucci Senior Vice President and General Manager, Personal Care | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.
Equity awards granted
Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
| Officer | Award | Grant date | Threshold units | Target units | Units granted | Maximum units | Exercise price | Grant date fair value |
|---|---|---|---|---|---|---|---|---|
| Alessandra Faccin Assis | PSU | ◇ | ◇ | ◇ | ◇ | ◇ | — | ◇ |
| Guillermo Novo | PSU | ◇ | ◇ | ◇ | ◇ | ◇ | — | ◇ |
| J. Kevin Willis | PSU | ◇ | ◇ | ◇ | ◇ | ◇ | — | ◇ |
| James Minicucci | PSU | ◇ | ◇ | ◇ | ◇ | ◇ | — | ◇ |
| Karl Bostaph | PSU | ◇ | ◇ | ◇ | ◇ | ◇ | — | ◇ |
| Osama M. Musa | PSU | ◇ | ◇ | ◇ | ◇ | ◇ | — | ◇ |
| William Whitaker | PSU | ◇ | ◇ | ◇ | ◇ | ◇ | — | ◇ |
| William Whitaker | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| William Whitaker | PSU | ◇ | ◇ | ◇ | ◇ | ◇ | — | ◇ |
Fiscal 2022, 2023, 2024 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.
Outstanding awards
Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
| Officer | Award | Unvested units | Market value of unvested units | Exercise price | Expires |
|---|---|---|---|---|---|
| Guillermo Novo | PSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| Osama Musa | RSU | ◇ | ◇ | — | — |
| PSU | ◇ | ◇ | — | — | |
| J. Kevin Willis | PSU | ◇ | ◇ | — | — |
| Alessandra Faccin Assis | RSU | ◇ | ◇ | — | — |
| PSU | ◇ | ◇ | — | — | |
| William Whitaker | PSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| James Minicucci | RSU | ◇ | ◇ | — | — |
| PSU | ◇ | ◇ | — | — | |
| Karl Bostaph | PSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Severance and change in control
The terms as written in the agreements.
Alessandra Faccin Assis
SVP & GM Life Sciences & Intermediates · Change-in-control agreement
| Severance multiple | ◇ |
| Change-in-control multiple | ◇ |
| Benefits continuation on change in control | ◇ |
| Excise tax treatment | ◇ |
| Non-compete period | ◇ |
| Non-solicit period | ◇ |
J. Kevin Willis
Former Senior Vice President and Chief Financial Officer · Change-in-control agreement
| Severance multiple | ◇ |
| Change-in-control multiple | ◇ |
| Equity acceleration on change in control | ◇ |
| Benefits continuation on change in control | ◇ |
| Benefits continuation | ◇ |
| Excise tax treatment | ◇ |
| Non-compete period | ◇ |
| Non-solicit period | ◇ |
James Minicucci
Senior Vice President and General Manager, Personal Care · Change-in-control agreement
| Severance multiple | ◇ |
| Change-in-control multiple | ◇ |
| Equity acceleration on change in control | ◇ |
| Benefits continuation on change in control | ◇ |
| Benefits continuation | ◇ |
| Excise tax treatment | ◇ |
| Non-compete period | ◇ |
| Non-solicit period | ◇ |
Karl Bostaph
Former Senior Vice President Operations · Change-in-control agreement
| Severance multiple | ◇ |
| Change-in-control multiple | ◇ |
| Equity acceleration on change in control | ◇ |
| Benefits continuation on change in control | ◇ |
| Non-compete period | ◇ |
| Non-solicit period | ◇ |
Osama Musa
Senior Vice President and Chief Technology Officer · Change-in-control agreement
| Severance multiple | ◇ |
| Change-in-control multiple | ◇ |
| Benefits continuation on change in control | ◇ |
| Benefits continuation | ◇ |
| Non-compete period | ◇ |
| Non-solicit period | ◇ |
William Whitaker
Senior Vice President and Chief Financial Officer · Change-in-control agreement
| Change-in-control multiple | ◇ |
| Benefits continuation on change in control | ◇ |
| Excise tax treatment | ◇ |
| Non-compete period | ◇ |
| Non-solicit period | ◇ |
| Clawback | ◇ |
Director compensation
What each non-employee director was paid.
Fiscal 2025
| Director | Fees earned in cash | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|
Susan L. Main Lead independent director | ◇ | ◇ | — | — | — | — | ◇ |
Suzan F. Harrison | ◇ | ◇ | — | — | — | — | ◇ |
Jerome A. Peribere | ◇ | ◇ | — | — | — | — | ◇ |
Sanat Chattopadhyay | ◇ | ◇ | — | — | — | — | ◇ |
Scott A. Tozier | ◇ | ◇ | — | — | — | — | ◇ |
Ashish K. Kulkarni | ◇ | ◇ | — | — | — | — | ◇ |
Steven D. Bishop | ◇ | ◇ | — | — | — | — | ◇ |
Guillermo Novo served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Director fee schedule
The standing retainers and premiums the board pays, as published.
| Board cash retainer | ◇ |
| Board equity retainer | ◇ |
| Total board retainer | ◇ |
| Lead independent director premium | ◇ |
| Audit committee chair | ◇ |
| Compensation committee chair | ◇ |
| Nominating and governance chair | ◇ |
Disclosed peer group
The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2024
- Albemarle Corporation ALB
- Avient Corporation AVNT
- Axalta Coating Systems Ltd AXTA
- Cabot Corporation CBT
- Element Solutions, Inc. ESI
- Entegris, Inc. ENTG
- FMC Corporation FMC
- H.B. Fuller Company FUL
- Ingevity Corporation NGVT
- Innospec Inc. IOSP
- Minerals Technologies MTX
- New Market Corporation symbol not shown
- RPM International Inc. RPM
- Sensient Technologies Corporation SXT
- Stepan Corporation SCL
- The Chemours Company CC
Say-on-pay history
Shareholder support for the compensation program, by year.
| Year | Meeting | Support | Votes for | Votes against | Abstentions |
|---|---|---|---|---|---|
| 2025 | January 20, 2026 | = | ◇ | ◇ | ◇ |
| 2024 | January 21, 2025 | = | ◇ | ◇ | ◇ |
| 2023 | January 23, 2024 | = | ◇ | ◇ | ◇ |
| 2022 | January 24, 2023 | = | ◇ | ◇ | ◇ |
| 2021 | January 25, 2022 | = | ◇ | ◇ | ◇ |
| 2020 | January 28, 2021 | = | ◇ | ◇ | ◇ |
| 2019 | January 30, 2020 | = | ◇ | ◇ | ◇ |
| 2018 | February 8, 2019 | = | ◇ | ◇ | ◇ |
| 2017 | January 25, 2018 | = | ◇ | ◇ | ◇ |
| 2016 | January 26, 2017 | = | ◇ | ◇ | ◇ |
Chief executive pay ratio
As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇
Ask our research desk — $99, 24h, every figure cited to its filing.
Sample answer — “What is the CEO’s total compensation?”
- Guillermo Novo (Chair of the Board and Chief Executive Officer), FY2025 total compensation $7,907,423 (base salary $1,152,332) [exec_comp, SEC accession 0001193125-25-312753, filed 2025-12-09]What this page does not include
Everything above is a fact Ashland disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Ashland sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $500Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $500Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $500Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion IntelligenceAdviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about accessMultiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion IntelligenceCitations
Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
308 figures on this page: 298 cited to the filing that reported them, 10 calculated from figures it prints.
298 cited to the filing
10 calculated from the filing
Documents cited
- 0001193125-26-019509Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001193125-25-312753CEO Pay Ratio
- 0000950170-25-007842Item 5.07 Submission of Matters to a Vote of Security Holders
- 0000950170-24-134511
- 0000950170-24-007993
- 0000950170-23-069398Summary Compensation Table
- 0000950170-23-001307
- 0000950170-22-000508
- 0001564590-21-004018Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001564590-20-002943Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001564590-19-002805Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001674862-18-000003Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001674862-17-000008Item 5.07 Submission of Matters to a Vote of Security Holders
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Ashland executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/ASH (accessed 2026).
Short form: data: Velarion
The Ashland brief, $500
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $500 for the board report; $900 for both.
14 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Ashland and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Peers Ashland discloses
The companies named in ASH's own disclosed peer group.
Albemarle CorporationAvient CorporationAxalta Coating Systems LtdCabot CorporationElement Solutions, Inc.Entegris, Inc.FMC CorporationH.B. Fuller CompanyIngevity CorporationInnospec Inc.Minerals TechnologiesRPM International Inc.Sensient Technologies CorporationStepan CorporationThe Chemours Company
Terms on this page
Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
author = {{Velarion Company Intelligence}},
title = {Velarion database: executive and board compensation data},
year = {2026},
version = {2026Q3},
doi = {10.5281/zenodo.22283854},
publisher = {Zenodo},
url = {https://doi.org/10.5281/zenodo.22283854}
}